TripleMed
PrivateLast Round
VC Round
Mar 21, 2024
Total Funding Raised
$2.38M
Company Overview
TripleMed is a medical device company that develops innovative and cost-effective solutions for the treatment of aortic aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
endovascular aneurysm repairEVARaortic aneurysm treatmentendoleak repairmedical devicepolymer implantvascular surgeryaneurysm sac fillingin-situ curingmedtechsiloxane polymerminimally invasive surgeryclinical trialvascular implant
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TripleMed Comparables
Compare TripleMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Memory Medical | 79% | |
| Endoron Medical | 79% | |
| Taurus Vascular | 71% | |
TripleMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 21, 2024 | ||||
| Series A | Sep 1, 2017 |
TripleMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brightlands Venture Partners | VC Round, Series A |
| LIOF | VC Round, Series A |
TripleMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TripleMed's valuation, stock price, and market status.